Back to today’s briefing

Story perspectives

FDA's $250K Singapore Trip Sparks Controversy Amid Shutdown

12/16/2025

36 7 Full Breakdown

Summary

Story summary

In December 2025, the U.S. Food and Drug Administration (FDA) sent 31 employees to Singapore for a conference during a government shutdown.
The trip cost more than $250,000.
The FDA approved the trip, which the agency described as "mission critical" for global drug development standards.
Critics argued the optics were poor during the shutdown as the conference, with about 500 global experts, sought to unify drug approval standards.

History

Historical Context

The FDA's Drug Quality and Security Act, enacted in 2013, aimed to enhance drug safety and regulatory standards, reflecting ongoing concerns about public health. The recent FDA conference in Singapore, costing over $250,000 during a government shutdown, highlights historical tensions between health initiatives and budget constraints, echoing past controversies over resource allocation that impact public trust in regulatory agencies.

1 of 2

Story summary

In December 2025, the U.S. Food and Drug Administration (FDA) sent 31 employees to Singapore for a conference during a government shutdown.
The trip cost more than $250,000.
The FDA approved the trip, which the agency described as "mission critical" for global drug development standards.
Critics argued the optics were poor during the shutdown as the conference, with about 500 global experts, sought to unify drug approval standards.

1 / 2